Vischer advised Loomis in connection with its acquisition of Kipfer Logistik, a Swiss logistics company specialising in temperature-controlled transport and storage for the pharmaceutical sector. The Vischer team Partner Benedict F. Christ (corporate/M&
Tags :Vischer
Vischer advised the selling part in connection with the deal that saw the University Hospital Basel (USB), a Swiss university hospital, acquiring St. Claraspital, an hospital in north-western Switzerland, from St. Clara and the Ingenbohl
Vischer advised the Canton of Basel-Stadt in connection with the implementation of the Eeurovision Song Contest (ESC). The city of Basel hosted the 2025 edition for a week. More than 500,000 visitors attended the event across different
Vischer advised the Canton Basel-Stadt in connection with its role as host of the UEFA Women’s EURO 2025. The competition attracted over 657,000 spectators to the stadium. A total of five matches took place in Basel,
Walder Wyss advised Energie 360° on its acquisition of Move Mobility from VISCHER acted as legal counsel to Primeo Energie, Groupe E and ewb. In connection with the deal Vischer advised the selling parties .Headquartered in
Vischer advised IT services and data center solutions specialist synaforce Group throughout its acquisition of ServerBase, a Swiss cloud platform based in Bachenbülach in the Canton of Zurich. The Vischer team Partner Jürg
Snyck completed its acquisition Invariant labs, an AI security research company and spin-off of ETH Zurich based in Zurich. In connection with the deal, Wenger Vieli advised the shareolders of the selling part, while Vischer
Vischer advised Easternmed Real Estate Capital in its acquisition of a new prime commercial property in Geneva. The building in question is home to a hotel residence. The company Headquartered in Nicosia and listed with
Vischer advised Swissroc Asset Management in connection with Swissroc Industrial Opportunities’ acquisition of a 4,200 m² light industrial building in the commune of Thônex (Geneva) from a professional investor. The 1991 building sits within the industrial
Vischer advised Mosanna Therapeutics in connection with its USD 80m Series A funding round. Headquartered in Basel, Switzerland, the clinical-stage biotech company, is working on a nighttime nasal spray to treat obstructive sleep apnea (OSA).
